Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125650392 | 12565039 | 2 | F | 20151226 | 20160729 | 20160718 | 20160805 | EXP | JP-ROCHE-1692182 | ROCHE | 69.91 | YR | F | Y | 54.60000 | KG | 20160805 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125650392 | 12565039 | 1 | PS | Atezolizumab | ATEZOLIZUMAB | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE PRIOR TO THE EVENT ON 22/DEC/2015 | 1150029 | 761034 | 1200 | MG | Q3W | ||||||
125650392 | 12565039 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE PRIOR TO THE EVENT ON 22/DEC/2015 | 14J010E | 125085 | 843 | MG | SOLUTION FOR INFUSION | Q3W | |||||
125650392 | 12565039 | 3 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE PRIOR TO THE EVENT ON 22/DEC/2015 | Y | 0 | 645 | MG | Q3W | ||||||
125650392 | 12565039 | 4 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | MOST RECENT DOSE PRIOR TO THE EVENT ON 22/DEC/2015 | Y | 0 | 314 | MG | Q3W | ||||||
125650392 | 12565039 | 5 | C | DIQUAS | DIQUAFOSOL TETRASODIUM | 1 | Unknown | DIQUAS OPHTHALMIC SOLUTION 3% | 0 | ||||||||||
125650392 | 12565039 | 6 | C | SANCOBA | CYANOCOBALAMIN | 1 | Ophthalmic | SANCOBA OPHTHALMIC SOLUTION 0.02% | 0 | ||||||||||
125650392 | 12565039 | 7 | C | GASTER | FAMOTIDINE | 1 | Unknown | 0 | TABLET | ||||||||||
125650392 | 12565039 | 8 | C | ATELEC | CILNIDIPINE | 1 | Unknown | 0 | TABLET | ||||||||||
125650392 | 12565039 | 9 | C | RESTAMIN A KOWA | 2 | Unknown | INDICATION- PREVENTION OF ALLERGIC REACTION | 0 | 10 | MG | TABLET | ||||||||
125650392 | 12565039 | 10 | C | RESTAMIN A KOWA | 2 | Unknown | SELECT IF ONGOING=NO | 0 | 10 | MG | TABLET | ||||||||
125650392 | 12565039 | 11 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | INDICATION- PREVENTION OF ALLERGIC REACTION | 0 | ||||||||||
125650392 | 12565039 | 12 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | SELECT IF ONGOING=NO | 0 | ||||||||||
125650392 | 12565039 | 13 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | .75 | MG | INFUSION | ||||||||
125650392 | 12565039 | 14 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | SELECT IF ONGOING=NO | 0 | .75 | MG | INFUSION | |||||||
125650392 | 12565039 | 15 | C | ALLELOCK | OLOPATADINE HYDROCHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
125650392 | 12565039 | 16 | C | ALLELOCK | OLOPATADINE HYDROCHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
125650392 | 12565039 | 17 | C | LOXOPROFEN EMEC | LOXOPROFEN | 1 | Unknown | 0 | 60 | MG | TABLET | ||||||||
125650392 | 12565039 | 18 | C | LOXOPROFEN EMEC | LOXOPROFEN | 1 | 0 | ||||||||||||
125650392 | 12565039 | 19 | C | GRAN | FILGRASTIM | 1 | Unknown | 0 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||||
125650392 | 12565039 | 20 | C | GRAN | FILGRASTIM | 1 | Unknown | SELECT IF ONGOING=NO | 0 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||
125650392 | 12565039 | 21 | C | CEFEPIME DIHYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
125650392 | 12565039 | 22 | C | CEFEPIME DIHYDROCHLORIDE | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | SELECT IF ONGOING=NO | 0 | ||||||||||
125650392 | 12565039 | 23 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | 0 | TABLET | ||||||||||
125650392 | 12565039 | 24 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | SELECT IF ONGOING=YES | 0 | TABLET | |||||||||
125650392 | 12565039 | 25 | C | VASOLAN | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | 0 | 5 | MG | |||||||||
125650392 | 12565039 | 26 | C | VASOLAN | VERAPAMIL HYDROCHLORIDE | 1 | Unknown | 0 | 40 | MG | |||||||||
125650392 | 12565039 | 27 | C | LACTEC | CALCIUM CHLORIDE ANHYDROUSPOTASSIUM CHLORIDESODIUM CHLORIDESODIUM LACTATE | 1 | Unknown | SELECT IF ONGOING=NO | 0 | ||||||||||
125650392 | 12565039 | 28 | C | ACELIO | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | 0 | 1000 | MG | |||||||||
125650392 | 12565039 | 29 | C | VEEN-D | DEXTROSE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125650392 | 12565039 | 1 | Non-small cell lung cancer |
125650392 | 12565039 | 2 | Non-small cell lung cancer |
125650392 | 12565039 | 3 | Non-small cell lung cancer |
125650392 | 12565039 | 4 | Non-small cell lung cancer |
125650392 | 12565039 | 5 | Dry eye |
125650392 | 12565039 | 6 | Dry eye |
125650392 | 12565039 | 7 | Gastritis prophylaxis |
125650392 | 12565039 | 8 | Hypertension |
125650392 | 12565039 | 13 | Nausea |
125650392 | 12565039 | 14 | Vomiting |
125650392 | 12565039 | 15 | Erythema |
125650392 | 12565039 | 17 | Arthralgia |
125650392 | 12565039 | 18 | Pyrexia |
125650392 | 12565039 | 19 | Neutrophil count decreased |
125650392 | 12565039 | 21 | Prophylaxis |
125650392 | 12565039 | 23 | Constipation |
125650392 | 12565039 | 25 | Atrial tachycardia |
125650392 | 12565039 | 27 | Atrial tachycardia |
125650392 | 12565039 | 28 | Pyrexia |
125650392 | 12565039 | 29 | Decreased appetite |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125650392 | 12565039 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125650392 | 12565039 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125650392 | 12565039 | 1 | 20151030 | 0 | ||
125650392 | 12565039 | 2 | 20151030 | 0 | ||
125650392 | 12565039 | 3 | 20151030 | 0 | ||
125650392 | 12565039 | 4 | 20151030 | 0 | ||
125650392 | 12565039 | 7 | 20151110 | 0 | ||
125650392 | 12565039 | 8 | 20151116 | 0 | ||
125650392 | 12565039 | 9 | 20151127 | 20151127 | 0 | |
125650392 | 12565039 | 10 | 20151222 | 20151222 | 0 | |
125650392 | 12565039 | 11 | 20151127 | 20151127 | 0 | |
125650392 | 12565039 | 12 | 20151222 | 20151222 | 0 | |
125650392 | 12565039 | 13 | 20151127 | 20151127 | 0 | |
125650392 | 12565039 | 14 | 20151222 | 20151222 | 0 | |
125650392 | 12565039 | 15 | 20151128 | 20160112 | 0 | |
125650392 | 12565039 | 16 | 20160113 | 0 | ||
125650392 | 12565039 | 17 | 20151130 | 0 | ||
125650392 | 12565039 | 19 | 20151203 | 20151206 | 0 | |
125650392 | 12565039 | 20 | 20160104 | 20160106 | 0 | |
125650392 | 12565039 | 21 | 20151203 | 20151208 | 0 | |
125650392 | 12565039 | 22 | 20151225 | 20151230 | 0 | |
125650392 | 12565039 | 23 | 20151206 | 20151206 | 0 | |
125650392 | 12565039 | 24 | 20151227 | 0 | ||
125650392 | 12565039 | 25 | 20151221 | 20151221 | 0 | |
125650392 | 12565039 | 26 | 20151221 | 0 | ||
125650392 | 12565039 | 27 | 20151221 | 20151221 | 0 | |
125650392 | 12565039 | 28 | 20151224 | 20151225 | 0 | |
125650392 | 12565039 | 29 | 20151225 | 20151230 | 0 |